163
Participants
Start Date
June 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
exenatide
subcutaneous injection (5mcg or 10mcg), twice a day
placebo
subcutaneous injection (equivalent volume to active dose), twice a day
Research Site, Peoria
Research Site, Tucson
Research Site, Santa Ana
Research Site, Indianapolis
Research Site, Topeka
Research Site, Wichita
Research Site, Baton Rouge
Research Site, St Louis
Research Site, Oklahoma City
Research Site, Goose Creek
Research Site, Spartanburg
Research Site, Dallas
Research Site, San Antonio
Research Site, Renton
Research Site, Ponce
Research Site, San Juan
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY